Neurosolutions was founded to provide technically demanding electrophysiology to the biopharmaceutical industry. Our highly qualified team of scientists deliver preclinical research solutions from the single cell right through to the whole animal tailored precisely to our client’s needs. We are comfortable working on single fee-for-service contracts right up to multiple member research teams driving forward development programs under FTE agreements or as a working partnership. We incorporate the latest technologies in our pursuit of electrophysiological excellence, and deliver exceptional results ahead of schedule.
![]()
We also provide animal behavioural and molecular biological services of the highest quality in parallel with our electrophysiological expertise. Neurosolutions has a wealth of experience in providing first class preclinical translational research into the study, treatment and prevention of mental disorders. Our track record can be demonstrated in our manuscript publications and our key strength is in developing precisely tailored research packages to target out client’s needs.
Whether it is in vitro or in vivo electrophysiological approaches, whole animal behavior or molecular biology techniques, our research teams will provide expert consultancy in putting together the study proposal you require, and our investigators will then rapidly deliver data of the highest quality to drive forward your research programs. Neurosolutions has extensive experience in delivering first class preclinical translational research into the study, treatment and prevention of neurodegenerative disorders, particularly around amyloid based animal models of Alzheimer’s disease. Our track record is demonstrated in our manuscript publications and our key strength is in developing precisely tailored research packages to target out client’s needs. Whether it is in vitro or in vivo electrophysiological approaches, whole animal behavior or molecular biology techniques, our research teams will provide expert consultancy in putting together the study proposal you require, and our investigators will then rapidly deliver data of the highest quality to drive forward your research programs. Disease Areas. Alzheimer’s Disease.
Parkinson’s Disease. Multiple Sclerosis. Huntington’s Disease Behavioural Tests. Open field: e.g. Object recognition test (ORT), Y-maze, Barnes maze.
Operant chambers: e.g.
Neurosolutions was founded to provide technically demanding electrophysiology to the biopharmaceutical industry. Our highly qualified team of scientists deliver preclinical research solutions from the single cell right through to the whole animal tailored precisely to our client’s needs. We are comfortable working on single fee-for-service contracts right up to multiple member research teams driving forward development programs under FTE agreements or as a working partnership. We incorporate the latest technologies in our pursuit of electrophysiological excellence, and deliver exceptional results ahead of schedule. We also provide animal behavioural and molecular biological services of the highest quality in parallel with our electrophysiological expertise. Neurosolutions has a wealth of experience in providing first class preclinical translational research into the study, treatment and prevention of mental disorders. Our track record can be demonstrated in our manuscript publications and our key strength is in developing precisely tailored research packages to target out client’s needs.
Whether it is in vitro or in vivo electrophysiological approaches, whole animal behavior or molecular biology techniques, our research teams will provide expert consultancy in putting together the study proposal you require, and our investigators will then rapidly deliver data of the highest quality to drive forward your research programs. Neurosolutions has extensive experience in delivering first class preclinical translational research into the study, treatment and prevention of neurodegenerative disorders, particularly around amyloid based animal models of Alzheimer’s disease. Our track record is demonstrated in our manuscript publications and our key strength is in developing precisely tailored research packages to target out client’s needs. Whether it is in vitro or in vivo electrophysiological approaches, whole animal behavior or molecular biology techniques, our research teams will provide expert consultancy in putting together the study proposal you require, and our investigators will then rapidly deliver data of the highest quality to drive forward your research programs. Disease Areas. Alzheimer’s Disease.
Parkinson’s Disease. Multiple Sclerosis. Huntington’s Disease Behavioural Tests. Open field: e.g. Object recognition test (ORT), Y-maze, Barnes maze.
Operant chambers: e.g.
Neurosolutions was founded to provide technically demanding electrophysiology to the biopharmaceutical industry. Our highly qualified team of scientists deliver preclinical research solutions from the single cell right through to the whole animal tailored precisely to our client’s needs. We are comfortable working on single fee-for-service contracts right up to multiple member research teams driving forward development programs under FTE agreements or as a working partnership. We incorporate the latest technologies in our pursuit of electrophysiological excellence, and deliver exceptional results ahead of schedule. We also provide animal behavioural and molecular biological services of the highest quality in parallel with our electrophysiological expertise.
Neurosolutions For Excel
Neurosolutions has a wealth of experience in providing first class preclinical translational research into the study, treatment and prevention of mental disorders. Our track record can be demonstrated in our manuscript publications and our key strength is in developing precisely tailored research packages to target out client’s needs. Whether it is in vitro or in vivo electrophysiological approaches, whole animal behavior or molecular biology techniques, our research teams will provide expert consultancy in putting together the study proposal you require, and our investigators will then rapidly deliver data of the highest quality to drive forward your research programs. Neurosolutions has extensive experience in delivering first class preclinical translational research into the study, treatment and prevention of neurodegenerative disorders, particularly around amyloid based animal models of Alzheimer’s disease.
Our track record is demonstrated in our manuscript publications and our key strength is in developing precisely tailored research packages to target out client’s needs. Whether it is in vitro or in vivo electrophysiological approaches, whole animal behavior or molecular biology techniques, our research teams will provide expert consultancy in putting together the study proposal you require, and our investigators will then rapidly deliver data of the highest quality to drive forward your research programs. Disease Areas. An Illegal Act and Other Stories.
Alzheimer’s Disease. Parkinson’s Disease. Multiple Sclerosis. Huntington’s Disease Behavioural Tests. Open field: e.g. Object recognition test (ORT), Y-maze, Barnes maze. Operant chambers: e.g.
Comments are closed.
|
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |